IBIN Introduced into Billion Dollar Blockchain Market by Hybrid Stock Exchange
Hybrid Stock Exchange, a blockchain based trading platform using the released IBIN as a blockshare identifier, are all set to adopt innovative features to sustain the needs of the ever growing industry. Watch the HYBSE trailer here: http://www.hybse.com
The International Securities Identification Number (ISIN) is a 12 character code that uniquely identifies a specific security, such as stocks, and is the most popular global securities identifier. With the pre-registration for issuers and users opened, the DIM Ecosystem introduces the International Blockshare Identification Number (IBIN), a 13 digit, unique serial number used by a company for listing on the Hybrid Stock Exchange or other Blockchain Exchanges.
Tradable securities on HYBSE currently include Cryptonized equity, Cryptocurrencies, Exchange-traded commodities, index, and more. Any issuers are able to apply for their IBIN at no charge. This limited time offer is available until August 31, 2018 or for the first 75 companies that register. More on http://www.ibin.io
The Data Interchange Module (DIM) cryptocurrency is a p2p, quantity-committed, secure, private and robust digital medium of exchange, built upon the NEM blockchain protocol.
Cryptonized assets such as intellectual property or company equity will be available to blockchain and average users through the gateway of HYBSE. DIM Currencies and cryptonised assets can be managed across the globe via computers and handheld devices using a state-of-the-art blockchain wallet called DEPOTWALLET with the mobile version currently in testing phase and soon to be released. The user friendly registration process includes a well thought out KYC model for issuers and users as well as a comprehensive due dillegence process for companies.
Mainstream equity markets suffer from downsides such as limited access for the average person due to very expensive fees, difficult registration proccesses with long waiting periods and challenging interfaces. HYBSE‘s blockchain-based platform looks to eliminate hurdles by allowing issuers and investors to conduct business on a secure and efficient platform. Lower costs, transparency, user friendly web interface, P2P trading, robust security, and the availability of a large pool of financial instruments are benefits enjoyed by HYBSE users.
HYBSE license of Dealers in Securities in Vanuatu, No. 17911.
DIM Foundation Ltd
Phone +2787 701 0914
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Alibaba’s Robust Ecosystem Supercharges 2018 11.11 Global Shopping Festival19.10.2018 13:15 | Tiedote
Alibaba Group Holding Limited (NYSE:BABA) today officially kicked off the 2018 11.11 Global Shopping Festival in China’s capital, promising this year’s mega-event will be the largest-ever in terms of scale and reach. Businesses within the Alibaba ecosystem will jointly offer hundreds of millions of consumers an enriching experience that supports their pursuit of high-quality products, entertainment and fast, reliable services. The Festival will also demonstrate the enthusiasm of consumers and brands embracing Alibaba’s New Retail strategy – the convergence of online and offline retail through technology. “This year marks the 10th anniversary of 11.11. On the back of China’s explosive digital transformation, the Festival’s astounding growth over the past decade has powered the steady growth of quality consumption sought by Chinese shoppers. The evolution also showcases the development of the Alibaba ecosystem over time expanding well beyond e-commerce,” said Alibaba Group CEO Daniel Zha
Real-world study shows using Giotrif®/Gilotrif® (afatinib) followed by osimertinib provides a median of 27.6 months of chemotherapy-free time in patients with EGFR mutation-positive NSCLC19.10.2018 13:08 | Tiedote
Boehringer Ingelheim today announced results from GioTag, a real-world retrospective study which examined the impact of first-line Giotrif®/Gilotrif® (afatinib) followed by osimertinib, in epidermal growth factor receptor mutation-positive (EGFR M+) non-small cell lung cancer (NSCLC) patients with acquired T790M mutations, the most common mechanism of resistance to first- and second-generation EGFR tyrosine kinase inhibitors (TKIs). The results showed that the sequential strategy was effective in delaying subsequent chemotherapy treatment and were published today in the journal Future Oncology. According to the study, the median time on treatment for sequential afatinib and osimertinib was 27.6 months. In this broad, real-world population, the clinical benefit was consistent across all patient subgroups, with particularly encouraging results seen in those with exon 19 deletion (Del19)-positive disease (median time on treatment 30.3 months) and Asian patients (median time on treatment 4
Clovis Oncology Presents Initial Results from the Ongoing Rubraca® (rucaparib) TRITON Program in Metastatic Castration Resistant Prostate Cancer (mCRPC) at ESMO 2018 Congress19.10.2018 13:01 | Tiedote
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced initial data from its ongoing Phase 2 TRITON2 clinical trial of Rubraca at the ESMO 2018 Congress (European Society for Medical Oncology). The data show a 44% confirmed objective response rate (ORR) by investigator assessment in 25 RECIST* /PCWG3** response-evaluable patients with a BRCA1/2 alteration. The median duration of response in these patients has not yet been reached. In addition, a 51% confirmed prostate specific antigen (PSA) response rate was observed in 45 PSA response-evaluable patients with a BRCA1/2 alteration. The TRITON2 results were the basis for Breakthrough Therapy designation for Rubraca as a monotherapy treatment of adult patients with BRCA1/2 mutated mCRPC who have received at least one prior androgen receptor (AR)-directed therapy and taxane-based chemotherapy, which was granted on October 2, 2018 by the U.S. Food and Drug Administration (FDA). These data will be highlighted in a poster authored by Dr. Wassim
EMVCo Publishes Draft EMV® Secure Remote Commerce Specification v0.9 for Public Comment19.10.2018 12:00 | Tiedote
EMVCo has today published a draft of its EMV® Secure Remote Commerce (SRC) Specification, which is available for download from the EMVCo website and open for a public comment period of 45 days, until Monday 3 December. The global technical body has made the decision to release a draft specification - EMV SRC Specification v0.9 – before finalising the specification to allow as many payment industry participants as possible, including merchants, card issuers and payment networks, the opportunity to review and contribute to v1.0 which will be published in 2019. The draft EMV SRC Specification provides a foundation that will enable the processing of e-commerce transactions in a consistent, streamlined fashion across a variety of digital channels and devices, including smartphones, tablets, PCs and other connected devices. When finalised, it is expected that v1.0 of the EMV SRC Specification will: Define interfaces to allow for secure exchanges of payment data across participants in the dig
Reorg Acquires Majority Stake in Debt Explained19.10.2018 11:00 | Tiedote
Reorg, a leading financial media and technology company, today announced it has acquired a controlling stake in London-based Debt Explained Limited, the leading provider of data and analysis on the European high-yield and leverage loan markets. Founded in 2009, Debt Explained creates and curates data and analysis on bond and loan deals through its proprietary data bases and unique scoring and bench-marking products. These allow for detailed trend analysis in the European high yield and leverage loan markets. The combination of Reorg and Debt Explained will make these tools available on a global basis, driving a new and unique subscriber experience in Europe, the United States and beyond. “Reorg’s partnership with Debt Explained will create the industry-leading product in the global non-investment grade credit markets,” said Kent Collier, founder and chief executive officer of Reorg. “This fits in perfectly with our strategic vision, and we look forward to building our business together
MapleStory 2 Hits 1 Million Account Downloads18.10.2018 23:43 | Tiedote
MapleStory 2, the newest leading free to play MMORPG in the illustrious and vibrant setting of Maple World, has officially hit 1 million account downloads, only a week after its launch. MapleStory 2 is available for download globally on Nexon Launcher and Steam. Since its official launch, MapleStory 2 has become one of the biggest MMORPGs on Steam and a beloved game for 1 million players due to its unlimited customization, quests, and its fun community. Due to its rapid growth, the game continues to increase its servers, especially the Oceania server, where player population continues to exceed expectations. To celebrate the occasion, MapleStory 2 will hold various events to commemorate the achievement and thank its players. MapleStory 2 1 Million Player Celebration Events: Double Bonus Item Drop Event: Starting Friday, Oct. 19 and going until Friday, Oct. 26, players will be able to earn double bonus items from normal adventure dungeons. Special Weekend Login Event: Beginning Saturday
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme